Future prospects in depression research.
Major depression is a common, disabling, and often difficult-to-treat illness. Decades of research into the neurobiology and treatment of depression have greatly advanced our ability to manage this disorder. However, a number of challenges remain. A substantial number of depressed patients do not achieve full remission despite optimized treatment. For patients who do achieve resolution of symptoms, depression remains a highly recurrent illness, and repeated episodes are common. Finally, little is known about how depression might be prevented, especially in individuals at increased risk. In the face of these challenges, a number of exciting research efforts are currently under way and promise to greatly expand our knowledge of the etiology, pathophysiology, and treatment of depression. This review highlights these future prospects for depression research with a specific focus on lines of investigation likely to generate novel, more effective treatment options.
Holtzheimer
Paul E
PE
Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Nemeroff
Charles B
CB
D000818:Animals; D003865:Major Depressive Disorder / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D009446:Neurobiology / Q000379:methods; D009490:Neurosecretory Systems / Q000503:physiopathology; D018377:Neurotransmitter Agents / Q000502:physiology; D012106:Research / Q000639:trends*; D012107:Research Design
D018377:Neurotransmitter Agents